World's Best Scientists 2026 revealed!
Børge G. Nordestgaard

Børge G. Nordestgaard

Award Badge
Best Scientists
2025
Award Badge
Medicine
Denmark
2026

D-Index & Metrics

Best Scientists

D-Index
192
Citations
163589
World Ranking
384
National Ranking
4

Medicine

D-Index
201
Citations
180076
World Ranking
177
National Ranking
2

Research.com Recognitions

  • 2026 - Research.com Medicine in Denmark Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in Denmark Leader Award
  • 2023 - Research.com Medicine in Denmark Leader Award
  • 2022 - Research.com Medicine in Denmark Leader Award

Overview

Børge G. Nordestgaard is affiliated with the University of Copenhagen in Denmark and has a primary research focus in the field of Medicine. Their work spans several subfields, including Surgery, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, and Epidemiology.

The scientist's research topics cover a wide range of areas linked to cardiovascular and metabolic health. Key topics include Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, Genetic Associations and Epidemiology, Liver Disease Diagnosis and Treatment, Chronic Obstructive Pulmonary Disease (COPD) Research, as well as Adipokines, Inflammation, and Metabolic Diseases.

Børge G. Nordestgaard has contributed extensively to scientific literature, with frequent publications appearing in venues such as Atherosclerosis, European Heart Journal, Journal of the American College of Cardiology, Circulation, and Clinical Chemistry.

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (2020, European Heart Journal)
  • Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement (2022, European Heart Journal)
  • Lipoprotein(a) Reduction in Persons with Cardiovascular Disease (2020, New England Journal of Medicine)
  • Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society (2021, European Heart Journal)
  • Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (2022, New England Journal of Medicine)

The scientist often collaborates with other researchers, with frequent co-authors including Shoaib Afzal, Anne Tybjærg-Hansen, Anne Langsted, Ruth Frikke-Schmidt, and Yunus Çolak. These collaborations reflect a consistent focus on cardiovascular and metabolic research topics.

Best Publications

  • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

    Paul M Ridker;Eleanor Danielson;Jacques Genest;Antonio M. Gotto

  • Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

    Paul M. Ridker;Eleanor Danielson;Francisco A. H. Fonseca;Jacques Genest

  • Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

    Bin Zhou;Rodrigo M Carrillo-Larco;Goodarz Danaei;Leanne M Riley

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

    Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg

  • Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women

    Børge G. Nordestgaard;Marianne Benn;Peter Schnohr;Anne Tybjærg-Hansen

  • Genome-wide association study identifies novel breast cancer susceptibility loci

    Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah

  • Lipoprotein(a) as a cardiovascular risk factor: current status

    Børge G. Nordestgaard;M. John Chapman;Kausik Ray;Jan Borén

  • Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

    M John Chapman;Henry N Ginsberg;Pierre Amarenco;Felicita Andreotti

  • Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.

    Pia R. Kamstrup;Anne Tybjærg-Hansen;Rolf Steffensen;Børge G. Nordestgaard

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

  • Triglycerides and cardiovascular disease

    Børge G Nordestgaard;Børge G Nordestgaard;Anette Varbo;Anette Varbo

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

    D Wormser;S Kaptoge;E Di Angelantonio

  • Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

    Paul M Ridker;Eleanor Danielson;Francisco Ah Fonseca;Jacques Genest

  • Large-scale genotyping identifies 41 new loci associated with breast cancer risk

    Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini

  • C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

    Stephen Kaptoge;Emanuele Di Angelantonio;Lisa Pennells;Angela M. Wood

  • Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

    Anette Varbo;Marianne Benn;Anne Tybjærg-Hansen;Anders B. Jørgensen

  • Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.

    Julia Kozlitina;Eriks Smagris;Stefan Stender;Børge G Nordestgaard

Frequent Co-Authors

Anne Tybjærg-Hansen
Anne Tybjærg-Hansen University of Copenhagen
Stig E. Bojesen
Stig E. Bojesen University of Copenhagen
Graham G. Giles
Graham G. Giles University of Melbourne
Hermann Brenner
Hermann Brenner German Cancer Research Center
Kenneth W. Muir
Kenneth W. Muir University of Manchester
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center
Paul D.P. Pharoah
Paul D.P. Pharoah University of Cambridge
Douglas F. Easton
Douglas F. Easton University of Cambridge
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Melissa C. Southey
Melissa C. Southey Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees and career pathways can broaden your opportunities within medicine and healthcare. Many professionals today are taking advantage of flexible study options to advance their careers or specialize further.

For registered nurses interested in becoming nurse practitioners, adn to np bridge programs offer a streamlined path from an associate degree in nursing to a master’s level qualification. This pathway helps nurses step into advanced clinical roles more efficiently.

Those interested in nutrition and wellness might consider a nutrition degree online. These programs can lead to careers in dietetics, public health, or community education, often without the need for in-person courses.

Healthcare administration is another growing field. Enrolling in top cahme accredited mha programs prepares students for leadership positions in hospitals, clinics, and healthcare systems—all through online study and reputable accreditation.

Finally, registered nurses can earn a bachelor’s degree through rn to bsn programs without clinicals, which are designed to fit into busy schedules and do not require additional onsite clinical hours.

Each of these online pathways supports lifelong learning and career advancement in the ever-evolving healthcare sector.

Best Scientists Citing Børge G. Nordestgaard

Trending Scientists

Recently Published Articles